Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,801 | -45,355 | -25,048 | -18,218 | -80,893 |
| Depreciation Amortization | 2,549 | 1,655 | 1,094 | 536 | 1,069 |
| Accounts receivable | -815 | N/A | N/A | -21,500 | N/A |
| Accounts payable and accrued liabilities | 1,065 | -390 | -55 | -376 | -544 |
| Other Working Capital | 1,833 | 3,346 | 2,851 | -3,539 | -2,540 |
| Other Operating Activity | 7,453 | 6,296 | 3,710 | 23,567 | 7,133 |
| Operating Cash Flow | $-53,716 | $-34,448 | $-17,448 | $-19,530 | $-75,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,046 | -31,709 | -37,579 | 9,750 | -3,324 |
| PPE Investments | -573 | -573 | -480 | -450 | -4,280 |
| Investing Cash Flow | $-22,619 | $-32,282 | $-38,059 | $9,300 | $-7,604 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -510 | -341 | -233 | -5 | -20 |
| Common Stock Issued | 1,903 | 1,654 | 403 | 367 | 154,532 |
| Financing Cash Flow | $1,393 | $1,313 | $170 | $362 | $154,512 |
| Exchange Rate Effect | -15 | -18 | 11 | 7 | 51 |
| Beginning Cash Position | 91,937 | 91,937 | 91,937 | 91,937 | 20,753 |
| End Cash Position | 16,980 | 26,502 | 36,611 | 82,076 | 91,937 |
| Net Cash Flow | $-74,957 | $-65,435 | $-55,326 | $-9,861 | $71,184 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,716 | -34,448 | -17,448 | -19,530 | -75,775 |
| Capital Expenditure | -573 | -573 | -480 | -450 | -4,280 |
| Free Cash Flow | -54,289 | -35,021 | -17,928 | -19,980 | -80,055 |